L A Speicher - Concepedia

Author

L A Speicher

Fox Chase Cancer Center

Also Known As

L A Speicher, L Speicher, L. A. Speicher, L. Speicher, L.A. Speicher, LA Speicher, Lisa A. Speicher

Publications

646

Citations

H-Index

Concepts

All Affiliations

Fox Chase Cancer Center

About

L A Speicher is an author at Fox Chase Cancer Center specializing in pharmacotherapy, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	256
2	Natural Sciences	1	1	68
3	Biochemistry	1	1	68
4	Cell Biology	1	1	68
5	Cellular Physiology	1	1	68

L A Speicher

Publications

646

Citations

H-Index

Page 1

	Year	Citations
Phase II study of estramustine and vinblastine, two microtubule inhibitors, in hormone-refractory prostate cancer. G. R. Hudes, Richard E. Greenberg, Robert L. Krigel, Journal of Clinical Oncology	1992	256
Combined antimicrotubule activity of estramustine and taxol in human prostatic carcinoma cell lines. L A Speicher, Linda R. Barone, K D Tew PubMed Medicinal ChemistryUrologyOncologyNm TaxolMitotic Spindle Apparatus	1992	141
Interaction of forskolin with the P-glycoprotein multidrug transporter Diane I. Morris, L A Speicher, Arnold E. Ruoho, Biochemistry Chemoprevention StrategyPharmacotherapySkov3 CellsCellular PhysiologyTumor Biology	1991	68
P-glycoprotein Binding and Modulation of the Multidrug-Resistant Phenotype by Estramustine L A Speicher, Linda R. Barone, A E Chapman, JNCI Journal of the National Cancer Institute	1994	68
Interaction of an estramustine photoaffinity analogue with cytoskeletal proteins in prostate carcinoma cells. L A Speicher, Naomi Laing, Linda R. Barone, Molecular Pharmacology	1994	37
The effects of estramustine on metaphase and anaphase in DU 145 prostatic carcinoma cells. V R Sheridan, L A Speicher, K D Tew PubMed	1991	29
WR-1065, the active metabolite of amifostine (ethyol®), does not inhibit the cytotoxic effects of a broad range of standard anticancer drugs against human ovarian and breast cancer cells David S. Alberts, L A Speicher, Mary F. Krutzsch, European Journal of Cancer Cytotoxic EffectsStandard Anticancer DrugsOncologyMedicineBreast Cancer Cells	1996	26
Resistance to the antimitotic drug estramustine is distinct from the multidrug resistant phenotype L A Speicher, V R Sheridan, AK Godwin, British Journal of Cancer Drug Resistance AnalysisMultidrug Resistant PhenotypePharmacologyAntimitotic Drug EstramustineClinical Pharmacology	1991	21

Page 1